Search results for: 'point 19'

02 Feb 2021  |  Global  |  Market Research

2021 Predictions— COVID-19 Accelerates CX Investments

Growth Opportunities Revealed by End Customers

Infographics

×

The COVID-19 pandemic wreaked havoc in 2020 and continues to harm people, businesses, and economies. Accelerated vaccine deployment, a strong rebound in consumer demand, faster services sector recovery could enable full GDP recovery by mid-2021 (optimistic scenario). Full recovery will be pushed out beyond 2021 in case of multiple fresh outbreaks, ...

21 Oct 2021  |  Europe  |  Customer Research

Impact of COVID-19 on Healthcare Contact Centers

Acceleration in WAHA, Self-Service & Cloud Investments

Infographics

×

The healthcare industry was hit hard by the pandemic as it tackled the toughest of challenges around the globe- slowing down the virus, managing hospital capacity, keeping its staff safe, and ensuring patient privacy and confidentiality. Contact centers were busy far beyond capacity, driving organizations of all sizes to accelerate investments in s...

Frost & Sullivan surveyed 661 IT decision-makers around the globe to IT/Communications to gain a deeper understanding of the impact of COVID-19 and their plans to exceed CX expectations as the world recovers from the pandemic. COVID-19 accelerated the move towards self-service, allowing many companies to invest in technology that deflects calls...

This research service covers the global market for POS systems. Detailed market trend analysis including drivers, and restraints are provided for the POS systems market for the following geographic regions - North America, Latin America, EMEA and Asia Pacific. Expansive unit shipment and revenue forecasts analysis are presented for each of these ge...

30 Apr 2020  |  Asia Pacific  |  Market Outlook

COVID-19—Implications for the Healthcare Industry, 2020

Winning Strategies and Key Opportunities that are Evolving During this Disruption

Infographics

×

A team of futurists, analysts, and consultants from the Global Transformational Health Research Team at Frost & Sullivan have come together to render a comprehensive analysis to predict the future of healthcare with COVID-19 disruption in perspective. This study provides actionable predictions and growth opportunities for major healthcare segments ...

Many predicted that 2020 would be the year that fifth-generation (5G) mobile technology moved from something discussed as “coming soon” to a reality in many consumers’ lives. The move to 5G will not be an overnight occurrence, but one planned to gradually evolve over the next decade. The evolution of 5G starts with the consumer market: the latest A...

19 Jun 2020  |  Global  |  Market Research

Impact of COVID-19 on the Space Industry

Insights on Meeting Increasing Demand While the Industry Demonstrates Resilience to Disruptions

Infographics

×

The COVID-19 crisis is impacting all industries, including space. However, the impact on the space industry is unique. This study presents the analysis of the COVID-19 crisis and its implications on the space industry, covering relevant segments including manufacturing, launch, downstream services, and investments. The study offers a brief analys...

Portable and ultraportable point-of-care ultrasound (POCUS) systems have gained prominence in recent years due to their versatility and ease of use. These devices allow clinicians to acquire high-resolution images in real time and enable fast and well-informed clinical decisions, particularly in care settings where mobility and user-friendliness ar...

20 Dec 2022  |  Global  |  Technology Research

Advances and Growth Opportunities in RNA Vaccines

Technology Innovations and Investments Bolster Next-generation Prophylactic and Therapeutic RNA Vaccines

Infographics

×

RNA therapeutics and vaccines have been around for a long time, but the COVID-19 pandemic enabled their mass-market commercialization. Industry players saw mRNA vaccines developed for COVID-19 as effective for reducing the impact of the SARS-CoV-2 virus in populations. Moderna emerged as the first player to develop and commercialize an mRNA vaccine...